Comparative efficacy and safety of caffeine citrate and aminophylline in treating apnea of prematurity: A systematic review and meta-analysis.

Author: JiangHuimin, LiYanan, LiuWenwen, MiaoYiqun, WangAihua, ZhangYuanyuan, ZhaoShuliang, ZhouYun

Paper Details 
Original Abstract of the Article :
BACKGROUND: Methylxanthine, including caffeine citrate and aminophylline, is the most common pharmacologic treatment for apnea of prematurity. However, due to the lack of high-quality evidence, there are no clear recommendations or guidelines on how to choose between caffeine and aminophylline. OBJ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484669/

データ提供:米国国立医学図書館(NLM)

Choosing the Right Path: Comparing Caffeine Citrate and Aminophylline for Apnea of Prematurity

Treating apnea of prematurity can feel like navigating a desert of uncertainty, with various treatment options available. This research is like a compass, guiding us through the landscape of these options by comparing the efficacy and safety of caffeine citrate and aminophylline. The authors conducted a systematic review and meta-analysis of the existing literature, seeking to provide evidence-based recommendations for clinicians.

Caffeine Citrate and Aminophylline: Two Paths Through the Desert

This research is like a desert oasis, providing a comprehensive comparison of two common treatments for apnea of prematurity. The authors found that caffeine citrate and aminophylline have similar therapeutic effectiveness in improving respiratory function. However, they also noted that caffeine citrate was associated with fewer side effects, such as tachycardia and feeding intolerance. These findings suggest that caffeine citrate may be a preferable option for treating apnea of prematurity.

Finding the Best Path for Apnea of Prematurity Treatment

This research is a valuable tool for making informed decisions about the treatment of apnea of prematurity. The authors' findings suggest that caffeine citrate may offer a safer and more effective option compared to aminophylline. It's a reminder that the desert of medical treatments is vast and complex, and careful consideration is needed when choosing the best approach for individual patients.

Dr. Camel's Conclusion

This systematic review and meta-analysis provide valuable insights into the comparative efficacy and safety of caffeine citrate and aminophylline for treating apnea of prematurity. The authors' findings suggest that caffeine citrate may be a preferable option, offering a safer and more effective approach to managing this condition. This research is a testament to the importance of continuous evaluation and comparison in the pursuit of optimal medical treatments.
Date :
  1. Date Completed 2022-09-22
  2. Date Revised 2022-10-04
Further Info :

Pubmed ID

36121807

DOI: Digital Object Identifier

PMC9484669

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.